Given that activation of D2R signalling has been shown to inhibit VEGF/VEGFR2 signalling [52, 60], we speculate that downregulation of endothelial D2R expression in chemotherapy-resistant tumours could potentiate increased VEGF/VEGFR2 signalling. Here, KDR is linked to neoplasm.